Harry Z. Rosengart

Harry Z. Rosengart

Fondateur chez Sunpharm Corp.

Finance
Health Services
Health Technology

Profil

Mr. Rosengart is President and CEO of HK & Associates, an investment and consulting firm, specializing in financial and strategic advice to small and medium-sized companies with an emphasis on life sciences.
He is also the founder of LigoTech, Inc., a privately held DNA/RNA and macromolecule bioseparations company employing 14 individuals.
For three years, he served as Chairman of its Board of Directors, President and CEO and is currently a Member of the Board of Directors.
He raised $5 million in two equity rounds of capital.
During his tenure, he consummated several licensing transactions, acquired Affinity Biotechnology and successfully integrated the acquisition into LigoTech and launched a number of products.
Mr. Rosengart is also co-founder of SunPharm Corporation, an anti-cancer drug development-stage company.
Mr. Rosenhart is active in a number of civic and professional organizations and holds a B.S.
in Chemical Engineering and an MBA from Rutgers University.

Postes actifs de Harry Z. Rosengart

SociétésPosteDébut
Fondateur 10/09/2009
Corporate Officer/Principal 10/09/2009
Tous les postes actifs de Harry Z. Rosengart

Anciens postes connus de Harry Z. Rosengart

SociétésPosteFin
DYADIC INTERNATIONAL, INC. Président 18/06/2008
Analyst-Equity -
Voir l'expérience en détail de Harry Z. Rosengart

Formation de Harry Z. Rosengart

Rutgers State University of New Jersey Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Harry Z. Rosengart

Relations

6

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
DYADIC INTERNATIONAL, INC.

Health Services

Entreprise privées3

Finance

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Harry Z. Rosengart